ONESOURCE SPECIALTY PHARMA
|
ONESOURCE SPECIALTY PHARMA Last 5 Year Cashflow Statement History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|
| Profit Before Tax | ₹-22 Cr | ₹-390 Cr | ₹-799 Cr |
| Adjustment | ₹285 Cr | ₹288 Cr | ₹605 Cr |
| Changes In working Capital | ₹-303 Cr | ₹-6.66 Cr | ₹19 Cr |
| Cash Flow after changes in Working Capital | ₹-40 Cr | ₹-109 Cr | ₹-176 Cr |
| Cash Flow from Operating Activities | ₹-47 Cr | ₹-109 Cr | ₹-165 Cr |
| Cash Flow from Investing Activities | ₹-300 Cr | ₹506 Cr | ₹-66 Cr |
| Cash Flow from Financing Activities | ₹417 Cr | ₹-384 Cr | ₹118 Cr |
| Net Cash Inflow / Outflow | ₹70 Cr | ₹13 Cr | ₹-112 Cr |
| Opening Cash & Cash Equivalents | ₹22 Cr | ₹9.41 Cr | ₹121 Cr |
| Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - |
| Cash & Cash Equivalent of Subsidiaries under liquidations | - | - | - |
| Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - |
| Effect of Foreign Exchange Fluctuations | - | - | - |
| Closing Cash & Cash Equivalent | ₹92 Cr | ₹22 Cr | ₹9.41 Cr |
Compare Cashflow Statement of peers of ONESOURCE SPECIALTY PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ONESOURCE SPECIALTY PHARMA | ₹15,554.1 Cr | -7.6% | 2.5% | -21.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,645.0 Cr | 2.9% | 3.6% | 0.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,625.0 Cr | 0.6% | -4.5% | 3.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹145,415.0 Cr | 2.1% | -0.4% | 31.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,664.0 Cr | 2.2% | -0.4% | 6.2% | Stock Analytics | |
| CIPLA | ₹100,480.0 Cr | 0.4% | -6.2% | -19.4% | Stock Analytics | |
ONESOURCE SPECIALTY PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ONESOURCE SPECIALTY PHARMA | -7.6% |
2.5% |
-21.4% |
| SENSEX | -1.9% |
-9.1% |
-0.2% |
You may also like the below Video Courses